Professor John Aaskov

Dr John Aaskov is Professor of Immunology and Virology at the Institute of Health and Biomedical Innovation, Queensland University of Technology and Director of the World Health Organization Collaborating Centre for Arbovirus Reference and Research.  His research interests include population dynamics of dengue viruses, ross river virus vaccine, emerging infectious diseases, public health in Asia and the Pacific.  Current projects include Vietnam Australia Dengue Project and dengue in Myanmar. Link to profile.


Associate Professor Kathy Andrews

Associate Professor Kathy Andrews holds an ARC Future Fellowship and leads the tropical parasitology group within the Drug Discovery and Design research program at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  Current research is focussed on the development of histone deacetylase (HDAC) inhibitors as new antimalarial drugs, characterising the role of class I and II HDACs on malaria parasite transcription and parasite intra-erythrocytic devgelopment, antimalarial activity of clinically utilised HIV drugs and their mode of action in malaria parasites, in vitro and in vivo antimalarial pharmacodynamic studies on natural product derived compounds, and the evaluation of novel antimalarial agents. Link to profile.

Professor Vicky Avery

Professor Vicky Avery is chief investigator in discovery biology at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  Her research interests are in drug discovery, cancer, malaria, trypanosomes, high content analysis and high throughput screening. Link to profile.




Dr Michelle Barker

Michelle Barker is the Programme Director of a multidisciplinary international consortium of researchers, the Vector Ecology and Control Network. The Vector Ecology and Control Network was formed to address the need for new strategies to eliminate malaria, and is developing resources to allow national malaria control managers, researchers, product developers, funding bodies and policy makers access to data on malaria transmission, as well as simulations of various scenarios for analysis. Michelle is a sociologist who has been was responsible for leading collaborative networks and organisational change processes, including the development of engagement frameworks and strategies. Her current research interest is in developing and implementing stakeholder engagement processes and strategies that contribute to better organisational outcomes.  She has worked in Australia, the United States, the United Kingdom and New Zealand. Link to profile.


Dr Michael Batzloff

Dr Michael Batzloff is research leader at the Institute for Glycomics, Griffith University.  His research interests focus on pathogen-host interaction and the development of therapeutics, including vaccine discovery, for pathogenic bacteria such as Streptococcus and Burkholderia. Link to profile.




Professor Alan Baxter

Professor Alan Baxter is head of Comparative Genomics at James Cook University.  He is a past President of the Australasian Society for Immunology and a member of the editorial boards of the Journal of Immunology, Immunology and Cell Biology and The Review of Diabetic Studies.  His work is funded by the NHMRC, MSRA and Lions Club. Link to profile.




Professor Ifor Beacham

Professor Ifor Beacham is research leader at the Institute for Glycomics, Griffith University and a Fellow of the Australian Society for Microbiology.  His research interests cover bacterial pathogenesis, molecular microbiology, gene regulation, melioidosis, and genetic analysis of Burkholderia pseudomallei. Link to profile.




Professor Kenneth Beagley

Kenneth Beagley is professor of immunology and Deputy Director of the Institute of Health and Biomedical Innovation, Queensland University of Technology.  His research interests include the development of vaccines to prevent chlamydial infections, the development of needle-free immunisation methods, the effects of chronic chlamydial infections on inflammation and immunity, sex hormone regulation of innate and adaptive immunity, the development of chlamydial vaccines for the koala, and the effects of chlamydial infection on spermatogenesis and the development of prostatitis.  He is the Australia-Pacific region councilor for the Society for Mucosal Immunology. Link to profile.

Professor Sue Berners-Price

Professor Sue Berners-Price is internationally recognised for her work in the field of medicinal inorganic chemistry, which involves the design and mechanism of action of gold and platinum-based anti-cancer agents.  She has had continuous funding from national competitive grants from the ARC or NHMRC since 1989, holds three patents and is the author of more than 100 peer-reviewed original research articles.  She is a Fellow of both the Royal Society of Chemistry and the Royal Australian Chemical Institute, has served on the editorial boards of three international journals, and is currently Associate Editor of the Journal of Inorganic Biochemistry.  She is Pro Vice Chancellor of Science, Environment, Engineering & Technology at Griffith University. Link to profile.

Professor David Blair

David Blair's background is in parasitology and genetics (including population genetics, phylogenetics, molecular systematics and genomics). He is associated with past and ongoing projects on schistosomiasis and paragonimiasis in China and was part of the team that published the genome of Schistosoma japonicum in 2009. He has collaborations with parasitologists in several Asian countries, and particular China, Japan, Vietnam and India.



Associate Professor Helen Blanchard

Associate Professor Helen Blanchard is research leader at the Institute for Glycomics at Griffith University and a Fellow of the Royal Society of Chemistry.  Her research interests are in protein structure-function, rational drug design, protein x-ray crystallography, molecular modelling, and the biochemistry of carbohydrate recognising proteins.  Current research projects include structure-based inhibitor design and structure-function studies of viruses, including rotavirus and metapneumovirus that utilise carbohydrate-recognition during their mechanisms of infection and of the carbohydrate-recognising proteins galectins that are involved in cancer progression. Link to profile.


Associate Professor Chris Brown

Chris Brown is Associate Professor in the School of Biomolecular and Physical Sciences at Griffith University.  His research expertise is in supramolecular and macromolecular chemistry, organic synthesis, bioorganic chemistry, biomolecular simulation and protein engineering. Link to profile.




Dr Petra Buettner

Dr Petra Buettner is Senior Lecturer at James Cook University and teaches in epidemiology, biostatistics and research methodology.  As part of the Skin Cancer Research Group, she is involved in intervention studies that try to prevent the occurrence of naevi in young children, studies on risk factors for non-melanoma skin cancer including viral agents and genetic mutations, and studies on the measurement of Vitamin D.  She is also involved in the development of an improved staging system for cutaneous melanoma and in studies concerning the clinical management of skin cancer. Link to profile.



Dr Graham Burgess

Dr Graham Burgess is Associate Professor of Veterinary Science at James Cook University.  His major research interest is the study of the pathogenesis and epidemiology of viral diseases of animals and man.  He established the biotechnololgy company TropBio which designs, manufactures and markets products for the veterinary and medical industry.  These products include monoclonal antibodies and ELISA diagnostic kits. Link to profile.



Professor Tom Burkot

Professor Tom Burkot is a Tropical Leader (Tropical Biosecurity) at James Cook University. He is a vector biologist and Orchestrator of the Vector Control Development Network which seeks to assemble all known data on malaria vector to make these data assessable to an integrated modeling platform to enable researchers, malaria control officials and policy makers to explore the impact on transmission of single and multiple vector control strategies on malaria transmission. He received his PhD from the University of Wisconsin-Madison and subsequently worked at the Walter Reed Army Institute of Research, the Papua New Guinea Institute of Medical Research, the Queensland Institute of Medical Research and the Centers for Disease Control and Prevention, as well as serving as a consultant to the Pacific Regional Vector Borne Diseases Control Project in the Solomon Islands and Vanuatu. His research is focused primarily on malaria transmission in the Asian-Pacific region but has included work on lymphatic filariasis, Lyme disease and a variety of viral arthropod borne diseases including dengue, West Nile virus, Rift Valley and O'nong-nong. His research has been supported by numerous funding bodies including the NHMRC, the NIH, WHO and the Bill and Melinda Gates Foundation. He has served on the Technical Review Panel of the Global Fund, been a subject editor for the Journal of Medical Entomology and has published more than 100 peer-reviewed papers. Link to profile.

Professor Jim Burnell

Professor Jim Burnell is involved in a range of projects involving the biological resources of North Queensland, including the development of rapid throughput screening assays and the screening of the Australian Institute of Marine Sciences marine collection for compounds with herbicidal and pharmaceutical activity.  He has an on-going interest in investigating possible alternative means of introducing a C4 photosynthetic pathway into food crops, and is a member of the C4 Rice Consortium.  He is Professor of Biochemistry and Molecular Biology at James Cook University. Link to profile.


Professor Nicholas Buys

Professor Nicholas Buys is Dean, Learning & Teaching (Health) at Griffith University. He is an international leader in human services and rehabilitation research. His areas of research include vocational and occupational rehabilitation, disability management, primary and secondary prevention of chronic disease in Aboriginal and Torres Strait islander people, arts-based interventions to promote health, mental health promotion and career development for children in out of home care. He has worked with a range of State, Federal, non for profit agencies and private employers both in Australia and overseas.



Dr Jason Byrne

Dr Jason Byrne is a Senior Lecturer in the Griffith School of Environment.  His research expertise is in urban nature parks and greenspace planning, equity and fairness in planning, open space and healthy cities, ecological modernisation and sustainability, and climate change adaptation and urban resilience.  Current research projects include urban greenspace and climate change adaptation in China and the Gold Coast. Link to profile.



Dr David Camp

Dr David Camp’s research interests include:

  • selection, synthesis and enumeration of molecular scaffolds to afford focused libraries for prosecution of chemical biology and drug discovery programs;
  • generation of natural product extract libraries compatible with high throughput screening that ultimately yield innovative leads for drug discovery.

In 2001, he returned to Griffith University to head the newly formed Biota and Compound Management group in the Natural Product Discovery collaboration between Griffith University and AstraZeneca.  Dr Camp was the driving force behind establishment of the Queensland Compound Library and was appointed Foundation Director to this national resource in 2007. Link to profile.

Associate Professor Tony Carroll

Associate Professor Tony Carroll is Deputy Head of the School of Environment at Griffith University.  He has research expertise in biodiscovery involving screening against molecular targets, isolation and structure elucidation of bioactive natural products, chemical and biological diversity analysis of marine invertebrates, molecular imaging of marine invertebrates, chemotaxonomy of ascidans and sponges, chemotaxonomy of plants from the families - Proteaceae, Myrtaceae and Elaeocarpaceae, marine and freshwater toxins, and chemical ecology of marine invertebrates. Link to profile.


Professor Cordia Chu

Professor Cordia Chu, Griffith University, has research expertise in settings-based integrated planning for environment and population health, research design and planning, health promotion theory and strategies, community development empowerment in reproductive health, community needs assessment and health policy formation, and workplace health promotion and safety management. Link to profile.



Associate Professor Alan Clough

Associate Professor Alan Clough, James Cook University, is widely recognised in Australia for his significant contribution to research and practice in the challenging and often neglected field of substance use problems in Indigenous communities.  He brings to his work the unique perspective of having lived and worked in remote Indigenous communities in the Northern Territory's 'Top End' for almost 20 years.  His research has expanded to include studies of alcohol-related assault around licensed premises in inner-city areas.  He is also supporting studies of HIV/AIDS in PNG, research capacity building in the Solomon Islands and studies of containment strategies for H1N1 ('swine flu') in Indigenous communities. Link to profile.


Associate Professor Mark Coster

Associate Professor Mark Coster is chief investigator in bioactive molecule synthesis at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  His research interests include the development of new and general synthetic methodologies with particular emphasis on efficiency and selectivity, the application of these methods to the synthesis of comple, biologically active natural products, and the design and synthesis of natural product analogues as potential therapeutic agents. Link to profile.



Professor Allan Cripps

Professor Allan Cripps is Pro Vice Chancellor for Health at Griffith University.  His key research directions over the last decade have focussed on developing a vaccine for bacterial infections of the respiratory tract and ear.  Drawing on his earlier work on the development of immunity in infants and children and immune mechanisms, he has been able to make a significant contribution to defining the criteria for the development of a successful vaccine against nontypeable Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae infections in the airways and middle ear. Link to profile.


Dr Melissa Crowe

Dr Melissa Crowe is Deputy Director of the Institute of Sport and Exercise Science at James Cook University.  Her research interests include exercise under hot and humid conditions, occupational heat stress, acclimatisation to heat and humidity, nutritional supplements and exercise performance, warm up and recovery for exercise performance, and core stabilisation. Link to profile.



Professor Pat Dale

Professor Pat Dale, from Griffith School of Environment, Griffith University, has research expertise in coastal policy, environmental law, mosquito management, remote sensing and salt marsh ecology. Link to profile.




Professor Norelle Daly

Norelle Daly Norelle Daly is a Professor at James Cook University and holds an ARC Future Fellowship. Her research interests are in structure-function studies of peptides, peptide based drug design, and NMR spectroscopy. Current projects include developing plant disulfide rich peptides as angiogenic agents and a scorpion venom peptide as a tumour-imaging agent. In addition, the potential of spider venom peptides in breast cancer is being explored. She has previously held an NHMRC Industry Fellowship and a Queensland Smart State Fellowship. Her work is supported by the NHMRC, ARC and National Breast Cancer Foundation, and she is the author of more than 100 peer reviewed publications. Link to profile.


Dr Peter Davey

Dr Peter Davey, Griffith School of Environment, Griffith University undertakes research in health and sustainable development planning, best practice planning and implementnation of Health City Approaches in local and other Asia-Pacific communities, the application of the 'seven-step' public health planning model designed for action planning and strategy implementation, community needs assessment, environmental protection and quarantine research, and public health and climate change mitigation. Link to profile.


Dr Rohan Davis

Dr Rohan Davis is group leader of drug discovery and design at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  Dr Davis' research interests include isolation and structure elucidation of bioactive natural products, biodiscovery involving high throughput screening against molecular targets, design and synthesis of libraries based on natural product scaffolds, discovery of novel secondary metabolites from fungi, and the identification of small molecule enzyme inhibitors using mass spectrometry. Link to profile.


Dr Aysin Dedekorkut-Howes

Dr Aysin Dedekorkut-Howes is Senior Lecturer in the Griffith School of Environment.  She has research expertise in environmental planning and natural resource management with particular focus on water resources management, decision making, specifically collaborative planning, consensus building and alternative dispute resolution, regional planning and natural resource management linkage, and growth management. Link to profile.



Professor Gregor Devine

Professor Greg Devine is head of the mosquito control laboratory at the Queensland Institute of Medical Research (QIMR). The focus of our group is to characterize, monitor and control the entomological determinants of arbovirus and malaria transmission in heterogeneous environments. This includes looking at i) the impact of species and strain differences (e.g. vector complexes and insecticide-resistant variants) on vector competence and ecological fitness, ii) the influence of environmental variables (urban structure, temperature) on stress, establishment and disease transmission, iii) novel means of insecticide delivery (e.g. the auto-dissemination of larvicides, mosquito sterilants, and the volatilization of potent but safe pyrethroids) and iv) the application of new technologies for monitoring and survey purposes (e.g. novel age-grading and mark-recapture techniques). Much of this work will be facilitated by our unique PC2 and PC3 insectaries where we will also provide the routine capacity to undertake disease transmission studies. We retain very strong links to Queensland local government and take a major role in helping them prioritize their operational research into mosquito and biting midge control. Professor Devine is an adjunct Associate Professorship at James Cook University, Cairns. Link to profile.




Professor Denise Doolan

Professor Denise Doolan is a molecular immunologist who heads the Molecular Vaccinology Laboratory at the Queensland Institute of Medical Research.  Her research investigates the molecular basis of immunity to disease, with a focus on malaria and model systems that can inform the basic immunology, mechanisms and antigenic targets of immunity, and efficacy of candidate vaccines.  She has specific expertise in the preclinical and clinical evaluation of molecular vaccine platforms (including plasmid DNA and recombinant virus vaccines), the delineation of mechanisms of cell mediated protective immunity, and the identification of novel vaccine candidates using immunomics and genome-wide screening approaches.  Key interest areas include malaria, vaccine development, immunology and functional genomics. Link to profile.

Associate Professor Jacinta Elston

Associate Professor Jacinta Elston, an Aboriginal and South Sea Islander woman from north Queensland is an independent ministerial appointee to the National Breast and Ovarian Cancer Centre (NNBOCC), and has previously served on the National Aboriginal and Torres Strait Islander Health Council, and the Research Committee of the National Health and Medical Research Council.  She holds the position of Associate Dean Indigenous Health in the Faculty of Medicine, Health and Molecular Sciences at James Cook University.  Her research interests include healthy aging in Indigenous Australians; health service issues in relation to Indigenous cancer patients; and Indigenous health workforce and services research.  Current research activity centres on the development of health research capacity within the Aboriginal and Torres Strait Islander workforce. Link to profile.

Dr Christian Engwerda

Christian Engwerda completed his PhD at LaTrobe University in Melbourne, and then spent 11 years working in the USA and UK.  This included 8 years at the London School of Hygiene and Tropical Medicine, where he worked as a Wellcome Trust Career Development Fellow.  For the past 7 years he has headed the Immunology and Infection Laboratory at the Queensland Institute of Medical Research which he established as a NHMRC R.D. Wright Career Development Fellow and currently runs as an NHMRC Senior Research Fellow.  Chris has made significant contributions to the fields of immunology and parasitology, having defined key immune-regulatory pathways during protozoan infections and identified new strategies to prevent disease caused by intracellular pathogens.  He is also involved in commercial research with biotechnology industry partners, and several discoveries made in his laboratory are now in commercial development.  Key interest areas are immunity to parasitic infections, the immunological basis for disease, malaria, visceral leishmaniasis. Link to profile.

Dr Katja Fischer

Dr Katja Fischer is head of the Scabies laboratory at the Queensland Institute of Medical Research.  She completed undergraduate training at the University of Freiburg, her PhD at the University of Wurzburg in Germany, followed by post-doc positions at QIMR.  Her primary research focus is molecular medical parasitology.  After ten years of Malaria research she joined the Sarcoptes scabiei Gene Discovery Project, opening entirely new opportunities for research on this neglected infectious disease previously inaccessible to molecular studies.  Her laboratory's current focus is on scabies mite proteins interfering with host defence, in particular with complement.  Key interest areas are molecular parasitology, parasite proteases, parasites and innate immunity, and immunopathology of bacterial skin infedctions related to scabies infections. Link to profile.

Professor Lee Fitzpatrick

Professor Lee Fitzpatrick's research focusses on the physiology of stress in cattle, the effects of stress on fertility of bulls, and the effects of nutrition on ovarian function in cows. He is a professor in the School of Veterinary and Biomedical Sciences, James Cook University. Link to profile.




Associate Professor Don Gardiner

A/Prof Gardiner first began his professional career as a scientist working within hospital pathology departments.  In 1987, he took a staff position at the Thursday Island Hospital in the Torres Straits of Far North Queensland and became the Laboratory Manager a year later.  In total, he spent five years working with the Indigenous peoples of North Queensland which led to an interest in both diseases of the tropics and diseases of poverty.  He completed his PhD at the University of Sydney in 1997.  Since then, his research focus has moved towards malaria, particularly in the area of rational drug design.  Key interest areas are molecular biology of Plasmodium falciparum, rational antimalarial drug design and transmission blocking therapies. 



Associate Professor Gail Garvey

Associate Professor Gail Garvey is Division leader of Epidemiology and Health Systems at Menzies School of Health Research, based in Brisbane. Her work to date has focused largely in the areas of medical and health education, Indigenous health workforce and more recently dementia and cancer. Her research to date has largely focussed on topics which have complimented her role in the institutions in which she has been employed. She has expertise in conducting studies of a qualitative nature particularly with Aboriginal and Torres Strait Islander people. She has a track record of working closely with the local Aboriginal communities and Aboriginal and Torres Strait Islander community organisations. Her strengths in building capacity amongst Indigenous and non-Indigenous have led to a substantial increase in research programs and staff employed on these projects. Further, she provides strong mentorship and guidance to Indigenous high school students (Spotlight on Science program); Indigenous students enrolled in degree programs (Indigenous Cadetships) and supervision of postgraduate students. Link to profile.



Dr Michelle Gatton

Dr Michelle Gatton is a member of Institute of Health Biomedical Innovation (IHBI) at the Queensland University of Technology.  Her research is focused on applying quantitative tools to improve public health, particularly related to mosquito-borne disease.  With training and experience in statistics, mathematics and biology, Dr Gatton has a unique skill set which has provided her opportunity to work on a number of diseases of national and international importance.  These include malaria, Ross River virus and Barmah Forest virus.  She also consults to the World Health Organization and Foundation of Innovative New Diagnostics (FIND) on matters related to malaria rapid diagnostic tests.  Recently Dr Gatton has joined the Mosquito Modelling Workgroup of the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program in an effort to establish better links between modelling of mosquito-borne disease and public health policy.  Key interest areas are mathematical modellihg of mosquito-borne diseases, disease surveillance and web-based decision support tools, malaria drug resistance, and malaria control and elimination strategies. Link to profile.

Professor Brendan Gleeson

Professor Brendan Gleeson is the Director of the Urban Research Program at Griffith University.  He specialises in urbanisation and urban governance, environmental theory and policy, and urban social policy.  His most recent research focus is urban resilience in the face of climate change and resource insecurity. Link to profile.




Professor Jonathan Golledge

Professor Jon Golledge is Head of the Vascular Biology Unit (VBU) at James Cook University and holds a conjoint position with the Townsville Hospital where he is Director of Vascular Surgery.  He holds an NHMRC Practitioners Fellowship.  The VBU carries out research for translation into improved management of peripheral artery diseases, including aortic aneurysm, carotid atherosclerosis and lower limb athero-thrombosis.  The work includes a range of pre-clinical studies (e.g. involving rodent models, cell/tissue culture, genomics and proteomics) and clinical investigations (e.g. biomarker studies, genetic association investigations and randomised trials).  VBU research projects have been funded by a range of international and national grants, e.g. from the National Institutes of Health ($1.4M 2005-10), NHMRC ($3M 2004-13), the National Heart Foundation, the Queensland Government, BUPA Foundation and Diabetes Australia.  In 2010, Professor Golledge was awarded a Senior Clinical Research Fellowship by the Queensland Office of Health and Medical Research and also led a successful bid for an NHMRC funded National Centre of Clinical Research Excellence for Peripheral Artery Disease.  He is a Fellow of the Royal College of Surgeons of England and the Royal Australasian College of Surgeons, and a member of the Australian and New Zealand Society of Vascular Surgery and the European Society of Vascular Surgery. Link to profile.

Professor Michael Good

Professor Michael Good is a Research Leader, Institute for Glycomics, Griffith University. Professor Good has spent 25 years researching and developing a cure for malaria.  His interests are in the field of immunity and immunopathogenesis to malaria and group A streptococcus/rheumatic fever, with particular relevance to the development of vaccines.  Previously, he was Director of the Queensland Institute of Medical Research, and he is Chair of the National Health and Medical Research Council of Australia, a past president of the Association of Australian Medical Research Institutes and past director of the Cooperative Research Centre for Vaccine Technology.  In 2009, Professor Good won the Australian Museum CSIRO Eureka Prize for Leadership in Science and in 2010 he was awarded the Australia Fellowship to continue his lifesaving work in combating malaria and streptococcus A. Link to profile.


Dr Sue Gordon

Dr Sue Gordon is a Senior Lecturer in Physiotherapy at James Cook University.  Her research interests include the experience of secondary lymphoedema and musculoskeletal physiotheray and she collaborates with the World Health Organization Filariasis Centre. Link to profile.




Dr Brenda Govan

Dr Brenda Govan is Senior Lecturer in Microbiology and Immunology at James Cook University.  Her research is focussed on the cellular and molecular interactions that occur between a host and a pathogen during infection. Link to profile.




Associate Professor Patricia Graves

Patricia Graves MSPH, PhD is Associate Professor at James Cook University, School of Public Health, Tropical Medicine and Rehabilitation Sciences, Cairns, Queensland, Australia, where she is Director of the WHO/JCU Collaborating Centre for Lymphatic Filariasis, Soil Transmitted Helminths and other Neglected Tropical Diseases. She also works for EpiVec Consulting in epidemiology and control of vector-borne diseases. Until recently, she was Epidemiologist with the Malaria Control Program, The Carter Center, Atlanta, GA, USA (2007-2011). She holds adjunct faculty appointments at the International Research Institute for Climate and Society at Columbia University, New York, USA and at the Liverpool School of Tropical Medicine, Liverpool, UK. Associate Professor Graves was educated at Cambridge University, UK (Natural Sciences), the London School of Hygiene and Tropical Medicine, London, UK (PhD) and the University of Colorado Health Sciences Center, Denver CO, USA (MSPH). She has conducted basic and applied research on malaria, filariasis and other diseases in a range of environments and countries including academic institutions (London School of Hygiene and Tropical Medicine, University of Colorado), in research laboratories (US National Institutes of Health; Queensland Institute of Medical Research), at field research institutes (Papua New Guinea Institute of Medical Research, Medical Research Council, The Gambia), for aid agencies and NGOs (AusAID Pacific Regional Vector Borne Diseases Project, The Carter Center), and at public health institutes (guest researcher at US Centers for Disease Control and Prevention). She has also worked successfully on implementation of malaria and other vector-borne disease control programs while assessing their impact during long or short-term consultancies and contracts in collaboration with national Ministries of Health in numerous countries in Asia, the Pacific and Africa as well as for international agencies, donors and NGOs (the World Bank, AusAID, WHO, USAID, The Carter Center). In addition, she is a founder member of the Cochrane Infectious Diseases Group (since 1995) doing systematic reviews and meta-analyses of interventions to prevent, treat or control malaria and other diseases, and has been author or editor with major input into several significant malaria reviews with policy implications for the Cochrane Library and the Institute of Medicine. Link to profile.


Dr Darren Gray

Dr Darren Gray, an infectious disease epidemiologist, is a Research Fellow at the University of Queensland in the School of Population Health, and an Adjunct Associate Professor at the Hunan Institute of Parasitic Diseases, China. He completed a Bachelor of Science (Microbiology) in 1999; Master of Science (Tropical Infectious Diseases) in 2001; Graduate Certificate in Public Health (Tropical Health) in 2003; and was awarded in 2008 a PhD (Population Health: Tropical Health) from the University of Queensland, Australia.  He has a track record in epidemiology, international and tropical health, medical parasitology, schistosomiasis, infectious disease transmission dynamics, clinical and field based research, statistical and mathematical modelling and data management. His current research investigates the transmission and control of schistosomiasis, tuberculosis, echinococcosis and the soil-transmitted helminths, some of the most prevalent and important bacterial and parasitic infections that cause much suffering and economic loss worldwide. He aims to develop new public health interventions against these pathogens that will lead to their sustainable control and eventual elimination.  Dr Gray is recognised internationally for his work on schistosomiasis epidemiology and control and has published in high quality journals, notably Lancet Infectious Diseases, Clinical Microbiology Reviews, PLoS Medicine and PLoS NTDs. He has been cited highly and was recently invited to write a clinical review for the British Medical Journal.  He has worked in international health since 2004 particularly Southeast Asia (China and the Philippines). Dr Gray also has 10 years clinical experience working in pathology and phlebotomy in Brisbane hospitals.  He has received awards from the National Health and Medical Research Council, Australia, Australian Society of Parasitology, University of Queensland and Griffith University. He currently supervises 2 PhD students; and is a member of the Australian Society for Parasitology and the American Society of Tropical Medicine and Hygiene. Link to school profile.


Dr Darren Grice

Dr Grice is Research Leader at the Institute for Glycomics.  His research interests include the synthesis of novel carbohydrate derivatives, mass spectrometry of carbohydrates and natural product chemistry. Link to profile.





Professor Lyn Griffiths

Professor Lyn Griffiths is Director of the Griffith Institute of Health and Medical Research at Griffith University.  Her research interests lie in genomics research, migraine gene studies, hypertension research and cancer research. Link to profile.




Dr David Harrich

David Harrich holds the appointment of Associate Professor from the School of Chemistry and Molecular Biosciences at the University of Queensland. He also holds a Future Fellowship awarded by the Australian Research Council Future Fellow and is Group Leader of the Molecular Virology laboratory at the QIMR Berghofer Medical Research Institute. His key interest areas include human immunodeficiency virus (HIV), virus drug targets, cellular protein required by HIV and RNA regulatory control of virus replication.  Link to profile.




Dr Simone Harrison

Dr Simone Harrison is Principal Research Fellow and Coordinator of the Skin Cancer Research Group at James Cook University.  Her research interests include risk factors for the development of melanocytic naevi in early childhood, epidemiology and prevention of melanoma and non-melanocytic skin cancers, studies of sun protection habits in early childhood settings, the efficacy of high UPF clothing in delaying/preventing the development of melanocytic naevi in early childhood, risky beliefs about the perceived benefits of therapeutic sun exposure in infancy and the post-partum period, and the relationship between human papilloma virus and non-melanocytic skin cancer.  She is a Fellow of the Australasian College of Tropical Medicine. Link to profile.

Associate Professor Andreas Hofmann

Associate Professor is Chief Investigator, Structural Chemistry, Eskitis Institute for Cell and Molecular Therapies, Griffith University. He has research interests in protein crystallography, biophysical methods, protein biochemistry and molecular modelling and computation.  His research focuses on the structure-function relationships of proteins involved in health and diseases, and current projects include proteins involved in infection, inflammation, neurodegeneration, cell development and cell growth. Link to profile.


Professor Yik-Hong Ho

Professor Yik-Hong Ho is Professor of Surgery at James Cook University.  His research interests include the outcomes of new verses existing surgical techniques pertaining to colorectal surgery, quality of life instruments to assess surgical outcomes, anorectal physiologic techniques, clinical surgical randomised controlled trials, and clinical laboratory translational research in colorectal cancer.  He is a Fellow of the Royal College of Surgeons of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow, the Royal Australasian College of surgeons, the Academy of Medicine and the International College of Surgeons. Link to profile.


Dr Wilhelmina Huston

Dr Wilhelmina Huston is an infectious diseases researcher and lecturer at the Institute of Health and Biomedical Innovation, Queensland University of Technology. Dr Huston's research interests lie in investigating the pathogenic factors from intracellular bacteria such as Chlamydia and Legionella.  Her research is particularly focussed on those factors which may be useful drug and diagnostic targets to develop improved ways to detect and treat these diseases. Link to profile.



Professor Michael Jennings

Michael Jennings is Professor of Molecular Biology and Deputy Director of the Institute for Glycomics, Griffith University.  His research interests include blycobiology of bacterial pathogens, vaccine development, evolution of host adapted bacterial pathogens, host-pathogen interactions, codon usage and molecular mechanisms and roles of phase variation in host adapted bacterial pathogens. Link to profile.




Professor Newell Johnson

Professor Johnson is Professor of Dental Research, Griffith University and has research expertise in the epidemiology of oral diseases, the epidemiology, oral manifestations and prevention of HIB diseases, the diagnosis and management of oral mucosal diseases, diagnosis and management of severe forms of periodontal diseases and the diagnostic oral and maxillo-facial histopathology. Link to profile.




Dr Malcolm Jones

Dr Malcolm Jones holds the appointment of Associate Professor of Veterinary Biology and Parasitology at the University of Queensland, a position he holds while maintaining his research focus at the Quensland Institute of Medical Research.  His primary research intrests lie in the cell biology and host-parasite interactions of helminth parasites of humans, most notably schistosomes.  His focus is on the role of a number of highly adapted molecules expressed at the surface of these helminths, and particularly how these molecules aid the parasite in surface homeostatis and immune evasion.  He has long-standing skills and passion for advanced microscopy techniques, which he has brought to his research in a range of innovative studies in medical parasitology.  Malcolm is a past president of the Australian Society for Parasitology, a Fellow of that society and currently serves on the editorial boards of four journals in parasitology. Link to profile.



Professor Brian Kay

Professor Brian Kay was previously Deputy Director of QTHA and a Director and Deputy Director of the Australian Centre for International and Tropical Health, the Head of the WHO Collaborating Centre for Environmental Management for Vector Control, and President of the Mosquito and Arbovirus Research Committee Inc.  He has published over 270 peer reviewed scientific papers mainly on mosquito-borne virus diseases and their vectors, their surveillance, risk management and control.  Besides Australia, he has worked in French Polynesia, Fiji, Tonga, Samoa, Brazil, Indonesia, Laos, Cambodia and Vietnam and acted as short-term consultant or advisor to government, the United Nations and industry.  Key interest areas include mosquito-borne arboviruses, surveillance and control, tropical health, and Dengue and Ross River viruses.  Professor Kay is a Fellow of the Australian Academy of Science. Link to profile.

Dr Milton Kiefel

Dr Milton Kiefel is research leader at the Institute for Glycomics, Griffith University with research interests in the chemistry of carbohydrates, rational drug design, new synthetic methods, organic synthesis and the biochemistry of carbohydrate recognising proteins. Link to profile.




Associate Professor Natkunam Ketheesan

Ketheesan is an academic at James Cook University and the team leader of the Infectious Diseases and Immunopathogenesis research group.  Key research interests include determining host-pathogen interactions in tropical infections and in particular diseases and complications caused by Burkholderia pseudomallei, Group A streptococcus, and Coxiella burnetii.  His group has developed and characterised experimental models for melioidosis, rheumatic heart disease and Q Fever.  Ketheesan's research is supported by grants from the NHMRC, ARC and Australian and Queensland governments. Link to profile.



Associate Professor Victoria Korolik

Associate Professor Victoria Korolik is research leader at the Institute for Glycomics with research interests in the pathogenicity of enteric bacteria, chemotaxis, adhesion and invasion of host cells by pathogenic bacteria through interaction with carbohydrate receptors, antimicrobial resistance, identification of microbial targets for novel chemotherapy development, and the molecular characterisation of an enteric pathogen Campylobacter jejuni. Link to profile.




Associate Professor Sarah Larkins

Sarah Larkins is Associate Professor in General Practice and Rural Medicine at James Cook University.  Her research interests revolve around Aboriginal and Torres Strait Islander health, particularly in the areas of maternal, child, family and reproductive health, and also in working with communities to develop, implement and evaluate sustainable interventions and improve access to health services for Indigenous Australians, rural residents, adolescents and other underserved populations.  Other interests include socially accountable health education, Indigenous research capacity-building and doctors' health. Link to profile.



Dr Colleen Lau

Dr Colleen Lau is a Senior Research Fellow in the Children’s Health and Environment Program at the Queensland Children’s Medical Research Institute. Her research interests are in the fields of infectious disease epidemiology, environmental health, travel medicine, tropical medicine, and disease surveillance. Her current projects include epidemiological studies on leptospirosis, malaria, and lymphatic filariasis, and the application of geographic information systems to explore environmental drivers of disease transmission. She is also involved in clinical research on travel vaccines, malaria prophylaxis, and illness in travellers. Colleen is a medical graduate of the University of Western Australia, and completed a Master of Public Health and Tropical Medicine at James Cook University and a PhD at the School of Population Health, University of Queensland. She is a Fellow of the Royal Australian College of General Practitioners and the Australasian College of Tropical Medicine. Apart from her research activities, Colleen also works as a travel medicine doctor and general practitioner. Link to profile.



Professor Peter Leggat

Professor Peter Leggat is Acting Head of the School of Public Health, Tropical Medicine and Rehabilitation Sciences at James Cook University.  He also holds visiting, adjunct or conjoint professorships at several universities, including the University of Witwatersrand, Queensland University of Technology, and the University of Newcastle.  He has been a consultant with several national and international organisations, including the Department of Defence, the Therapeutic Goods Authority and the World Health Organization.  His main research interests include tropical and travel medicine, occupational and military health, and health professions eduction.  He has published more than 400 peer reviewed journal papers and 20 monographs as well as contributing more than 70 chapters.  He has presented more than 300 papers at national and international meetings, including the 60th E. Sandford Jackson Memorial Lecture of the Australian Medical Association in 2008.  Professor Leggat is Deputy Editor-in-Chief for the Journal of Travel Medicine, Editor for Industrial Health, Executive Editor for the Annals of the ACTM and Consulting Editor for the Archives of Environmental and Occupational Health.  A former Fulbright Scholar and recipient of numerous research awards, he is also a former Director-General of the World Safety Organization and Past President of the Australasian College of Tropical Medicine.  He is a Fellow of 10 national and international professional organisations and was elected a Member of the International Commission for Occupational Health in 2010. Link to profile.

Associate Professor Anthony Leicht

Associate Professor Anthony Leicht is Director of the Institute of Sport and Exercise Science at James Cook University.  His research is focussed on autonomic nervous system and exercise, cardiovascular exercise physiology, exercise assessment methods, and exercise and peripheral vascular disease.  He is an Associate Investigator on the NHMRC funded National Centre of Clinical Research Excellence for Peripheral Artery Diseases, and a Fellow of Exercise and Sports Science Australia and the European College of Sport Science. Link to profile.



Dr Andreas Lopata

Dr Andreas Lopata is team leader of the Molecular Immunology Group at the Comparative Genomic Centre at James Cook University and Adjunct Associate Professor in the School of Applied Sciences at RMIT University. He completed his undergraduate training at the University of DÏ‹sseldorf (Germany) followed by a joined research/lecture position at the National Health Laboratory Services and the University of Cape Town (South Africa). His primary research interest is on the interaction of food borne proteins with our immune system and the characterization of inflammatory proteins from the food-borne parasite Anisakis. His group developed several murine models on allergic reactions to food and tropical parasites resulting in clinical investigations and novel diagnostics. The research activities resulted in over 60 peer-reviewed publications, over 100 conference presentations, 5 novel proteins entrys, four PhD and twelve MSc (research) completions and currently eight PhD students. His work is funded by the NHMRC, Asthma Foundation Victoria, ABRS, and Advanced Manufacturing CRC. Link to profile.

Professor Alex Loukas

Professor Alex Loukas holds an NHMRC Senior Research Fellowship and is editor-in-chief of the International Journal for Parasitology. His major research interest is the molecular basis of host-parasite interactions, with a particular focus on characterising the functions of proteins secreted by helminths (worms) that parasitise humans in developing countries. Research projects include the development of vaccines for human hookworm disease and schistosomiasis, molecular pathogenesis of infection with the carcinogenic liver fluke, characterising the secretomes of parasitic helminths using proteomics, and human helminths as therapies for autoimmune and allergic diseases. His research is supported by international and national funding bodies including the Bill and Melinda Gates Foundation, NHMRC (program and project grants) and NIH. He is the author of more than 150 peer-reviewed publications and has received numerous awards for his research. Link to profile.

Professor John McBride

John McBride is Professor of Medicine at James Cook University, and combines his academic and teaching role at the Cairns Base Hospital campus with clinical responsibilities in Infectious Diseases and Clinical Microbiology.  His research interests span dengue fever, rickettsial diseases, tropical medicine, clinical trials (including vaccine studies), HIV in resource poor settings, fever investigation, pathogen discovery and infrared thermal imaging.  In 2003, he spent three months working wtih the national HIV AIDS support project in PNG establishing the antiretroviral program for the country, and has continuing research interests in the country relating to the role of male circumcision in the prevention of HIV and the epidemiology of dengue.  He is an acknowledged expert on dengue fever. Link to profile.

Professor James McCarthy

Professor McCarthy is a clinical and laboratory researcher in Infectious Diseases, at QIMR focussing on tropical and parasitic infections. Research projects currently underway in his laboratory include work on drug resistance in human scabies (funded by NHMRC and QLD Health-Smart State Grant) and hookworm infection (funded by WHO), novel diagnostics for parasite infections (funded by ARC, WHO and FIND) and the relationships between HIV and malaria (funded by Abbott pharmaceuticals), malaria in pregnancy, and experimental human malaria infection.

He has an active role in in clinical trialsincluding as named investigator in over 20 clinical trials in the last 5 years. These include serving as Principal Investigator for two first-in-man clinical trials of infectious diseases vaccines. He has led the Pre-IND submission to the US FDA and has a good working understanding of the Regulatory environment. Link to profile.


Professor Robyn McDermott

Professor Robyn McDermott (MBBS, MPH, PhD, FAFPHM) is a public health doctor and Head of the Centre for Chronic Disease Prevention, recently established as a partnership between JCU and Queensland Health in Cairns and serving rural and remote communities in far north Queensland with 5 year funding to 2017.

Her research interests are in chronic disease epidemiology, clinical quality improvement and disease prevention. She has chaired NHMRC Grant Review Panels for Projects, Fellowships and Capacity Building Grants and has had continuous NHMRC funding as lead investigator since 1998, totalling more than $12 million.


Professor Don McManus

Don McManus is Professor at Queensland Institute of Medical Research.  Schistosomiasis japonica is a serious parasitic disease in southern China, where infection with Schistosoma japonicum remains a public health issue despite intensive control.  Our ongoing research involves studies from the bench to the field: determining the effects of the drug artemether against S. japonicum infection and the effectiveness of combined artemether and praziquantel treatment in patients; increasing knowledge of the pathogenesis of advanced schistosomiasis; determining the importance of buffalo infections in the persistence of human schistosomiasis transmission impacting on future integrated schistosomiasis control; undertaking genomics and post-genommics research on S. japonicum molecules as new intervention targets; and validation of a mathematical model for improved and sustainable schistosomiasis morbidity control for China.  The research has contributed to the design of equitable schistosomiasis control options, promoting local economic development/improved health.  Consequently, the Chinese authorities have removed bovines from a number of sentinel villages to determine the long term impact on disease transmission.  In a land-mark Nature article, we described the complete genomic DNA sequence for S. japonicum, work central for identification of new targets for vaccination and diagnosis.  Our research resulted in: 90 peer-reviewed publications; two patents; seven PhD graduates; seven post-docs mentored; 60 Chinese field/clinical staff being involved in the collaboration; 45 international/national conference invitations; extensive media coverage and new national/international collaborations.  Key interest areas are tropial medicine and vaccines, schistosomiasis, echinococcosis. Link to profile.


Dr David MacLaren

Dr David MacLaren is Senior Research Officer at James Cook University.  His research focusses on HIV prevention in Melanesia (PNG and Solomon Islands), the public health of Kwaio people in Malaita, Solomon Islands, and the social and cultural determinants of health.  He has worked for an NGO in post conflict Kosovo and evaluated chroic disease management in Cape York and Torres Strait. Link to profile.



Associate Professor Graeme Maguire

Graeme Maguire is a specialist physician in general internal and respiratory medicine with experience in health service provision, health-related research and health policy and protocol development in the north of Australia, particularly for Aboriginal and Torres Strait Islander peoples.  He collaborates with colleagues in Papua, Indonesia undertaking work relating to tuberculosis and malaria.  His current research and health service development interests include chronic lung disease, rheumatic heart disease, remote specialist outreach, addressing tobacco for Indigenous Australians, Primary healthcare-based rehabilitation and tuberculosis. Link to profile.


Professor Suresh Mahalingam

Prof Mahalingam has an international reputation in the field of viral pathogenesis and has spent the last 15 years investigating the interactions between viruses and their hosts. He obtained his PhD from the John Curtin School of Medical Research at the Australian National University. He is currently Professor of Virology at the Institute for Glycomics, Griffith University and Group leader of the Emerging Viruses and Inflammation Research Group. His research interests include investigating mechanisms of; how mosquito-borne viruses cause arthritis; how respiratory viruses exacerbates asthma; how viruses evade the immune system; investigating viral factors that enable arboviruses to adapt in mosquitos; and designing and developing antivirals against viruses. His key scientific achievements: (i) First to discover that strains of V. cholerae are resistant to vibriostatic compounds, (ii) First to show that IFN-inducible chemokines mediate antiviral effects, (iii) First to show the existence of Th1/Th2 immune responses in a viral model, (iv) First to show that the signalling protein STAT6 is a susceptibility locus for poxvirus infection, (v) First to show that viral infection via Fc receptors suppress type I IFNs, (vi) First to show that DNA vaccines against IL5 can bypass B cell tolerance, (vii) First (with M. Heise) to establish a model for viral arthritides, (viii) First to establish a role for macrophages in RRV disease, (ix) First (with R. Tindle) to establish a polytope vaccine against hMPV, (x) First (with P. Foster) to demonstrate a role for eosinophils in viral immunity, (xi) First to show that macrophage and macrophage-derived factors are responsible for viral arthritis; (xii) First to establish a drug (Bindarit) to treat viral arthritis; (xiii) First to show that anti-TNF therapy is unlikely to have utility in treating alphaviral arthritides. Link to profile.

Associate Professor George Mellick

Associate Professor George Mellick is Chief Investigator, Clinical Neurosciences, Eskitis Institute for Cell and Molecular Therapies, Griffith University. He was trained in chemistry and biochemistry at the University of Queensland completing an Honours degree in Natural Products Chemistry. He became a Project Leader in the Centre for Genomics and Bioinformatics, Karolinska Institute, Sweden after being awarded a STINT Fellowship (Swedish Foundation for International Cooperation in Research and Higher Education) (2000). In 2004 he was appointed Lecturer in Medicine at the University of Queensland and later joined the staff of Griffith University as an Associate Professor (2006). A/Prof Mellick’s research interests include investigating the pathogenesis, aetiology and epidemiology of neurodegenerative diseases such as Parkinson's disease; and influence of complex interactions between genetic and environmental factors in relation to disease risk. Link to profile.


Associate Professor Wayne Melrose

For more than two decades, A/Prof Wayne Melrose has been involved with ground-breaking parasitology research and public health campaigns in PNG, Timor-Leste and the Pacific Islands.  His research interests include epidemiology, immuno-biology, diagnosis and control of lymphatic filariasis and intestinal parasites, neglected tropical diseases, general parasitology, tropical public health and tropical medicine, anaemia in tropical populations, medical laboratory science, human and comparative haematology, and bioterrorism and biosecurity. 


Associate Professor Nigel Morrison

Associate Professor Nigel Morrison is a researcher at the Griffith Health Institute.  His research interests include the genetic causes of complex chronic diseases that affect a large proportion of the population, rheumatoid arthritis, prostate cancer, osteoporosis and gene cloning and large scale identification of gene function. Link to profile.




Associate Professor Reinhold Muller

Associate Professor Reinhold Muller is Senior Epidemiologist and Biostatistician at James Cook University.  He undertakes interdisciplinary research collaborations with a wide variety of clinicians, public health workers and biologists and his research interests lie in quantitative research methodology in epidemiology, occupational health, the management of spinal pain syndromes and cardiology. Link to profile.



Associate Professor Jason Mulvenna

Associate Professor Jason Mulvenna is a laboratory head at QIMR Berghofer Institute. His primary interests are the development of novel drugs and vaccines for a range of helminth parasites and the identification of biomarkers for inflammation based cancers. He holds a NHMRC Career Development Fellowship and is funded by the NHMRC, ARC and NIH.




Dr Alan Munn

Dr Alan Munn's research interests include intracellular lipid and membrane protein trafficking processes and how these are exploited by viruses, the role of the actin cytoskeleton in signal transduction pathways that control cell proliferation and cell migration, and pathogenic fungi and their potential role in the spread of papilloma virus infection.  Dr Munn has more than 20 years of research experience in the membrane trafficking field with funding from the Australian Research Council.  His lab uses experimental approaches such as yeast two-hybrid protein interaction test, expression and purification of recombinant proteins, site-directed mutagenesis, protein bead pulldown assays, fluorescence microscopy and various membrane trafficking assays. Link to profile.



Professor Richard Murray

Professor Richard Murray is Head of the School of Medicine & Dentistry at James Cook University with a career focus on Aboriginal health, rural medicine, public health, tropical medicine and the needs of underserved populations.  He spent 14 years working in the remote Kimberley region of Western Australia, including 12 years as the Medical Director of the Kimberley Aboriginal Medical Services Council.  His research interests include meeting the needs of medically underserved populations, health workforce innovation, chronic disease and application of evidence, information technology and quality enhancement systems in health care practice.  Professor Murray is a Fellow of the Royal Australian College of General Practitioners and the Australian College of Rural and Remote Medicine. Link to profile.

Professor Peter O'Rourke

Peter O'Rourke is the Senior Biostatistician with the Queensland Institute of Medical Research / Royal Brisbane Women's Hospital Statistics Unit, a member of ACITH, Adjunct Professor in the School of Public Health at the Queensland University of Technology, and Adjunct Professor and Honorary Research Consultant in the School of Veterinary Science at the University of Queensland.  His primary role is to provide statistical consultancy to researchers and clinicians at QIMR and RBWH and to collaborate in their research.  His previous roles were as Reader in Biostatistics in the School of Population Health at the University of Queensland and as a biometrician with the Queensland Department of Primary Industries.  His biostatistical research interests include problem formulation, study design, data analysis, interpretation and workforce development with applications in public health, epidemiology, health systems, mental health, chronic and infectious disease and translational research. Link to research group.

Associate Professor Michael Oelgemöller

Associate Professor Michael Oelgemöller is leading the Applied Photochemistry Group at James Cook University. His research activities comprise drug development, synthetic organic (photo)chemistry, solar chemistry, the development of new synthesis tools, water quality, water treatment and drug stability. His group has developed several novel phototransformations and has utilized them for the synthesis of biologically active compounds, for example methyleneisoindolinones or anti-malarial endoperoxides. A special research focus has been solar chemistry, i.e. the implementation of renewable solar energy into chemical production processes. Other research areas dealt with the development of novel synthetic photochemistry tools for the pharmaceutical R&D community, e.g. photochemistry in micro reactors (‘lab-on-a-chip’). Within this area, his group has teamed up with Zagaya/Amyris to develop affordable anti-malaria treatment based on artemisinin. Recently, the group has launched a second research stream on water quality and photochemical water treatment. This more applied area deals with the detection of hazardous pollutants and microorganisms in water, their impact on public health and their destruction using photochemical techniques. In collaboration with Prof. Glass at JCU, his group is also interested in the stability of pharmaceutical formulations and cosmetics, in particular sunscreens, towards tropical conditions. Link to profile.

Dr Ian Peak

Dr Ian Peak is research leader at the Institute for Glycomics, Griffith University.  His research interests include bacterial pathogenicity, the interactions of diseases-causing bacteria with host cells, bacterial carbohydrates, the role of bacterial carbohydrates in disease, the potential of bacterial carbohydrates as vaccine candidates and drug targets, the biosynthetic pathways of carbohydrates in bacteria, and the use of bacterial enzymes in the production of synthetic carbohydrates. Link to profile.



Dr Natalie Pecheniuk

Dr Natalie Pecheniuk is Lecturer at Queensland University of Technology.  Her lab is focussed on the mechanisms of the biochemical or genetic risks on blood coagulation pathways and also on investigating in a translational research setting how they associate with clinical conditions which show a thrombotic phenotype or excessive coagulopathy.  Topics include the role of plasma lipoproteins in modulating procoagulant and anticoagulant pathways and their interplay between venous and arterial diseases, the role of extracellular nucleic acids in blood coagulation and the crosstalk between coagulation and inflammation in clinical disease. Link to profile.

Associate Professor Sally-Ann Poulsen

Associate Professor Sally-Ann Poulsen leads the Chemical Biology program at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  She has held continuous research intensive appointments both in academia and industry, including the tenure of two highly competitive research fellowships (ARC QEII Fellowship and Howard Florey NHMRC/Royal Society Fellowship).  Professor Poulsen's research expertise encompasses:

  • medicinal chemistry - this is applied to the design and synthesis of enzyme inhibitors involved in human diseases focussing on cancer and malaria
  • native state protein mass spectrometry - to investigate native state protein-ligand noncovalent complexes for drug discovery
  • in situ chemistry - for fragment-based drug discovery and lead optimisation
  • developing new small molecule tools for application in living cell biolabelling, imaging and quantitative analysis.

Her group has established a very strong record and international reputation in drug discovery targeting carbonic anhydrases.  She has successfully developed a large selection of compounds that are novel, potent, selective, non-toxic and drug-like. Link to profile.

Professor Ron Quinn

Professor Ron Quinn is Director, Eskitis Institute for Cell and Molecular Therapies, Griffith Univeristy. Professor Ron Quinn's research interests include:

  • biodiscovery involving high throughput screening against molecular targets, isolation and structure elucidation of bioactive natural products
  • design and synthesis of receptor ligands and enzyme inhibitors
  • understanding of natural product recognition for biosynthetic enzymes and correlation with therapeutic targets as a rational approach to drug discovery.

He was elected Fellow of the Australia Academy of Technological Sciences & Engineering (2003) and received the RACI Adrien Albert Award (2004).  Professor Quinn initiated collaboration with AstraZeneca (1993) to explore natural products as potential drugs. This collaboration is one of the largest industry/university collaborations in Australia ($100 million in industry investment).  Professor Quinn was appointed Director of the Eskitis Institute for Cell and Molecular Therapies in 2003. Link to profile.

Associate Professor Simon Reid

A/Prof Simon Reid is an epidemiologist at The University of Queensland's School of Population Health with an interest in research to improve the detection and control of infectious diseases with a particular emphasis on zoonotic diseases such as leptospirosis and influenza. His international experience 9both research and programmatic) includes PNG, Indonesia, the Philippines, Vietnam, Fiji and most of the other countries in SE Asia. His past research included th edevelopment and validation of a number of diagnostic assays and the development of a bio-economic model to predict the outcomes (financial, biological and demographic) of control interventions for trypanosomiasis in livestock in the Philippines. He will focus his future research on complex diseases such as leptospirosis and vector-borne diseases. Link to profile.


Professor Scott Ritchie

Professor Scott Ritchie is Professorial Research Fellow at James Cook University, combining this with his role as medical entomologist at the Tropical Public Health Unit in Cairns where key responsibilities are the management of mosquito-borne diseases such as dengue, malaria and Japanese encephalitis.  His research interests include the biology and ecology of mosquito-borne diseases, the management and emergency control of dengue, strategies for the surveillance and control of exotic mosquitoes and mosquito-borne diseases, and the impact of climate change on risk of vector-borne disease transmission.  He is currently active in field trials of Wolbachia in the dengue vector Aedes aegypti.  Professor Ritchie's work is funded by NHMRC, the Bill and Melinda Gates Foundation, CSIRO and private industry.  He is an editor for Journal of Medical Entomology and has over 150 peer-reviewed publications. Link to profile.

Professor Allen Ross

Professor Allen Ross is a Physician Scientist, Chair of Public Health and Director of Population Health Research at Griffith University.  His expertise and research interests lie in the realm of public health medicine, tropical infectious diseases, disease control, vaccination and adjuvant discovery.  He has designed, implemented and coordinated multi-faceted infectious disease projects in numerous locations of the developing world.  His papers on infectious diseases, tropical and international health have been published in top ranking journals such as the New England Journal of Medicine, Lancet Infectious Diseases, British Medical Journal, Clinical Microbiology Reviews, Clinical Infectious Diseases, International Journal of Epidemiology, and the Journal of Immunology.  He is a committee member of the Global Network for Neglected Tropical Diseases and the Australasian Faculty of Public Health Medicine Accreditation Subcommittee. Link to profile.

Dr Tanya Russell

Tanya Russell is a Principal Research Officer at James Cook University and is trained in Mosquito Ecology and Control as well as Environmental Ecology. Her interests are to conduct applied research that aims to develop, evaluate and promote the delivery of malaria vector control interventions that are affordable, effective and environmentally sound. Her focus is to support vector control operations by understanding the population ecology of mosquito vectors and the impact of vector phenotypes on effectiveness of malaria control interventions. She aims to fill these research gaps with both empirical (field-based) and theoretical (modelling) support. She has experience managing large entomological and ecological projects and in particular experience in mosquito collections, estimating entomological inoculation rates, village-scale trials, using experimental huts and semi-field systems, biodemography and multivariate and spatial statistics. She has worked in Australia, Asia, The Pacific and Africa.

Associate Professor Zoltan Sarnyai

Zoltan Sarnyai is Associate Professor of Pharmacology in the Discipline of Physiology & Pharmacology at the School of Veterinary and Biomedical Sciences, Faculty of Medicine, Health and Molecular Sciences at James Cook University based in Townsville.
A/Prof Sarnyai has a strong interest in stress and mental health and is developing projects to study stress and its biological manifestations in Indigenous people. One is a collaborative project with A/Prof Alan Clough on stress and cannabis withdrawal on Indigenous prison inmates. The other aims to assess health effects of stress in Indigenous communities and is a collaborative effort involving Stanley Nangala, Head of School of Indigenous and Aboriginal Studies at James Cook University and Jacinta Elson and Sarah Larkins JCU Medical School. In addition, A/Prof Sarnyai is interested in studying novel compounds from tropical marine sources for their antidepressant potentials.



Dr Patrick Schaeffer

Dr Schaeffer's research interests are broadly based on the study and applications of biomolecular interactions and in particular Protein-DNA interactions, with a current focus on developing innovative nano-biotechnologies for the discovery, characterisation and quantification of such interactions. Link to profile.



Associate Professor Jamie Seymour

Jamie Seymour has been researching and working with venomous and dangerous animals for over 20 yrs with his present interest being "Why do animals have venom?" Based in Cairns, in Northern Australia, an area that has an over abundance of venomous animals, he is uniquely placed to study the ecology and biology of Australia's venomous species. He has been successfully involved in programs designed to decrease the envenomings of humans by jellyfish, namely in Australia, Timor Leste (for the United Nations), Thailand and Hawaii. His research has been directly responsible for changes in the present treatment protocol for Australian jellyfish stings. He established and is the director of the Tropical Australian Venom Research Unit (TASRU) which is now recognised as one of the premier research groups in the world for the studies of the ecology and biology of box jellyfish and research into medical treatment of box jellyfish envenomings. Link to profile.


Professor Louis Schofield

Professor Louis Schofield is an International Research Scholar of the Howard Hughes Medical Institute and co-founder of Ancora Pharmaceuticals Inc.  He shares the Directorship of QTHA with his ongoing research work at the Walter and Eliza Hall Institute. A recognised authority in the immunology and pathogenesis of infectious diseases, he has research programs covering basic molecular sciences, product development and commercialisation, epidemiology and public health.  His approach to malaria has resulted in promising vaccine development programs and he is involved in clinical trials in Papua New Guinea and Africa. He has published several key articles, including in Nature and Science, and has received over 4,000 citations to date. Link to profile.

Professor Paul Scuffham

Paul Scuffham is a Professor in Health Economics and Director of a new Centre for Applied Health Economics at Griffith University.  His research interests span a wide range of issues including modelling costs and benefits of health care interventions, econometrics, public health (especially cardiology, mental health, injury preventnion, vaccines and telemedicine), valuation of health outcomes, and comparing the effectiveness, efficiency and equity of health systems.  He has worked with a wide range of organisations, including pharmaceutical, biotechnology and medical device companies, the UK Department of Health and several UK health authorities, the Australian Department of Health and Ageing, and non-government organisations such as the Royal National Institute for the Blind. Link to profile.

Associate Professor Neil Sipe

Associate Professor Neil Sipe is Head of Urban and Environmental Planning and is affiliated with the Griffith Health Institute and the population health and urban research programs at Griffith University.  His research interests in the use of geographic information systems to manage and control mosquitos, the impact of oil prices on Australian cities, the challenges in implementing performance based planning, and the influence of land use and urban form on travel behaviour. Link to profile.



Dr Lee Skerratt

Dr Skerratt is a Senior Research Fellow studying wildlife biosecurity and tropical zoonosis in the Tropical Infectious Diseases Research Centre at James Cook University.  His research interests are in the field of epidemiology and pathogenesis of infectious diseases and zoonoses of free-living animals. His current projects are on zoonoses of dingoes in the Wet Tropics, avian influenza in wild aquatic birds in northern Queensland, emerging diseases of frogs in northern Queensland and New Zealand, epidemiology and pathogenesis of chytridiomycosis in Australian frogs, improving biosecurity in global amphibian trade,  risk of tabanids introducing surra into Australia, fasciolosis in south east Asia, tick paralysis in spectacled flying foxes and health of Proserpine rock wallabies.  He is a member of the Australian College of Veterinary Scientists, the Universities Focus Group of the Australian Wildlife Health Network and the Wildlife Disease Association and Regional Chair of the IUCN/SSC Wildlife Health Specialist Group for Australia - New Zealand and South Pacific. He received the Barry Laing Munday Recognition Award for contributions to Wildlife Disease Research and Education in 2007. Link to profile.



Dr Tina Skinner-Adams

Dr Tina Skinner-Adams is at Griffith University. She has been involved in the investigation of drug action, target identification and malaria parasite biology since 1993. Dr Skinner-Adams’ current research is focused on developing new anti-malaria drugs, understanding the clinical consequences of HIV protease inhibitor antimalarial activity and characterizing the role of plasmepsins in malaria parasites. Link to group profile.




Professor Nick Smith

Professor Nick Smith is a Tropical Research Leader at James Cook University.  His research is devoted to studying how parasites and their hosts interact, with particular emphasis on immune responses to parasites and developing vaccines to fight parasitic disease.  He has been funded by the ARC, the Swiss National Fund, World Health Organisation and the Rural Industries Research and Development Corporation.  He is National Convenor of the ASP's Network for Parasitology. Link to profile.




Emeritus Professor Rick Speare

Emeritus Professor Rick Speare, AM, has made major contributions to research in the control of lymphatic filariasis, intestinal parasites, scabies and head lice and more recently he has worked on using hookworms as therapy for autoimmune disease and in emerging infectious diseases, particularly those originating in wildlife.  He led the team which has been internationally recognised for the identification of factors causing the global decline in frog populations.  Rick's research has been carried out in Australia, PNG, Africa, Tuvalua and Korea.  He is a Member of the General Division of the Order of Australia and holds fellowships in the Australian Faculty of Public Health Medicine and the Australian College of Tropical Medicine. The many awards throughout his career have included the CSIRO Medal in 2000, the Frank Katz Memorial Medal for Service to Medical Education in 2001 and the Ashdown Medal in 2006. Link to profile.

Dr Graeme Stevenson

Dr Graeme Stevenson is group leader at the Eskitis Institute for Cell and Molecular Therapies, Griffith University.  His research expertise is in organic synthesis, medicinal chemistry, cheminformatics and drug design. Link to profile.




Professor Donald Stewart

Professor Donald Stewart is a program convenor in the School of Public Health at Griffith University, has research expertise in health promotion, mental health, health and ageing, and public health services. Link to profile.





Professor Andreas Suhrbier

Professor Andreas Suhrbier is head of the Immunovirology Group at the Queensland Institute of Medical Research, a Principle Research Fellow with the National Health and Medical Research Council, Professor at Griffith University, and Adjunct Associate Professor at the University of Queensland.  He has over 110 publications in the fields of virology, immunology and cancer therapeutics.  He is an inventor on 16 patents, 12 have been commercialised, 7 cover products in human clinical trials, 3 cover products in phase III trials.  He is, and has been, a consultant for a number of local and international biotechnology companies.  Currently funded research projects include chikungunya virus (related to Ross River virus) arthritis, role of SerpinB2 in inflammation, chaperonin 10 as a drug against autoimmune disease, PEP005 as a topical anti-cancer chemotherapy.  Key interest areas are alphaviruses, macrophages, immunotherapeutics, cancer. Link to profile.


Dr Jing Sun

Dr Jing Sun is senior lecturer in Biostatistics at School of Public Health, Griffith University. Her current research ranges in a number of areas including evaluation of health promotion and health survey related projects, health promotion program development in Aboriginal and Torres Strait Islander communities, promotion of mental and physical health in chronic disease patients and prevention of chronic disease in Australia and China, development of art-based program to prevent chronic disease, and obsessive compulsive disorder in school students. She is currently collaborating with a number of organisations including Queensland Aboriginal and Islander Health Council, Community Controlled Health Services in Queensland, Queensland Music Festival, Arts and Health Foundation in Australia; Peking University in China, China Center for Disease Control and prevention, Jiangsu Centre for Disease Control and Prevention, and Shenyang Normal University in China.


Professor Peter Timms

Professor Peter Timms is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia at Queensland University of Technology.  His research team is developing new diagnostic procedures and vaccines for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genetics, biology and pathogenicity.  He also has significant experience in the commercialisation of biotechnological inventions, both through his successful involvement with the QUT-discovered gene chip technology, which was licenced to Affymetrix, as well as diagnostic applications through the CRC for Diagnostics.  He is a Fellow of the Australian Society for Microbiology and was recognised for his major contributions to the discipline of microbiology in 1998 by winning the prestigious Australian Society for Microbiology Frank Fenner Research Award. Link to profile.

Dr Joe Tiralongo

Dr Joe (Giuseppe) Tiralongo is located at the Institute for Glycomics, Griffith University.  His research focusses on Sialobiology (biosynthesis and expression of sialic acids in prokaryotic and eukaryotic organisms), specifically the role of sialic acids in human disease, including microbial pathogenesis and cancer development.  In particular, Dr Tiralongo is interested in the potential of host-pathogen interactions mediated through sialic acids as drug targets and the design of specific inhibitors of cancer cell surface silylation as potential novel anti-metastatic agents.  He has expertise in the biochemistry and cell biology of sialic acid research, including sialoglyconjugate detection, isolation and analysis, recombinant protein and membrane-protein expression and purification, and glycan and protein array technologies. Link to profile.



Professor Istvan Toth

ARC Australian Professorial Fellow Istvan Toth is Director of Pharmaceuticals TetraQ and Group Leader IMB Division of Structural Biology at the University of Queensland. Professor Toth was a Postdoctoral Fellow at Carleton University, Ottawa Canada (1974-76, Prof J.W. ApSimon). He returned to Hungary to work as a Research Associate (1977-82), then Scientific Group Leader (1982-1987) at the Central Research Institute for Chemistry, Hungarian Academy of Science. Professor Toth joined the School of Pharmacy at the University of London in 1987 as a Senior Lecturer and Royal Society sponsored Senior Research Fellow. He became a Reader in Medicinal Organic Chemistry in 1994 before relocating to the University of Queensland in 1998. Professor Toth’s major research interests are drug delivery, immunoadjuvants, carbohydrates, lipids, peptides, nucleosides and nucleotides. Link to profile.



Associate Professor Katharine Trenholme

Associate Professor Katharine Trenholme is a Senior Research Fellow at the Queensland Institute of Medical Research. She has a PhD in the field of malaria cell biology from the University of Glasgow and an MSc in Applied Parasitology and Medical Entomology from the Liverpool School of Tropical Medicine.  Her research focuses on identification of novel intervention points in the malaria parasite life cycle and the application of rational drug targeting.  This includes the development of new research tools and the translation of fundamental biological research into new interventions for the control of malaria.  Specific research areas include the pathway of haemoglobin degradation by intraerythrocytic stages of P.falciparum and gametocytogenesis as a potential therapeutic target for transmission blocking strategies in P falciparum. She is also a key member of a Brisbane based team undertaking experimental human malaria infection studies. Link to research group.

Professor Kim Usher

Professor Kim Usher is Professor of Nursing at James Cook University and is Director of Research and Research Training for the School of Nursing, Midwifery and Nutrition, as well as Associate Dean of Research Training for the University.  Research interests include psychotropic medications, reflective practice, Indigenous health and mental health, and nursing workforce issues.  Interest in the Pacific and tropical areas have led to Fellowship of the Cairns Institute - a centre set up to support research on underserved populations.  She is a Fellow of the Australian and New Zealand College of Mental Health Nurses and the Royal College of Nursing Australia and Director of the World Health Organization Collaborating Centre recently established at JCU. Link to profile.

Dr Patricia Vallery

Dr Patricia Vallery is a Research Officer at the Queensland Institute of Medical Research and a Lecturer at The University of Queensland. Before moving to Australia in 1992, Patricia Vallery's background was clinical.  Since moving into research in 1995, she has produced 29 scientific papers, of which about half are on Indigenous Health.  Her initial significant contribution to medical research was in Cancer Epidemiology, her PhD being on the causes of Ewing's Sarcoma (ES).  She conducted a national case-control study of ES, the only analytical study of ES in Australia to date.  Patricia started working in Indigenous Health research via a large study of asthma in children in the Torres Strait.  More recently, with colleagues, she has tested the hypothesis that additional education for Indigenous children with asthma, delivered by Indigenous Health Care Workers, improves asthma outcomes.  Her first-author Lancet publication is her most significant contribution to Cancer in Indigenous Australians, showing that advanced cancer at diagnosis, reduced treatment uptake and high rates of co-morbidities amongst Indigenous patients are some of the factors leading to poorer cancer outcomes compared to other Australians.  Dr Vallery's current work on Cancer in Indigenous Queenslandres is on supportive care needs.  Together with colleagues, she is validating the cultural sensitivity of an existing supportive care needs survey and adapting it for use with Australian Indigenous people with cancer.  This will be followed by a cross-sectional study to assess the supportive care needs of all adult Indigenous patients hospitalised for their cancer. Link to profile.

Professor Mark von Itzstein

Professor Mark von Itzstein is Director of the Institute for Glycomics, Griffith University.  He has won world fame for his design and synthesis of a drug which treats one of the scourges of humanity - influenza.  In 1996, he was one of the joint recipients of the Australia Prize for his relational design of the anti-influenza drug.  His research interests include the biology and chemistry of carbohydrates, rational drug design, enzymes in organic synthesis, enzyme mechanisms, new synthetic methods, organic synthesis and the biochemistry of carbohydrate recognising proteins.  He is an elected Fellow of the Australian Academy of Science and a Fellow of the Royal Australian Chemical Institute. Link to profile.


Dr Jeff Warner

Dr Jeff Warner is Senior Lecturer at James Cook University.  His research interests include infectious disease epidemiology, developing world health institutional strengthening particularly PNG, and medical laboratory science professional development. Link to profile.





Professor Maxine Whittaker

Maxine A. Whittaker, MBBS, MPH, PhD, FAFPHM is the Professor of International and Tropical Health and Director of the Australian Centre for International and Tropical Health at the University of Queensland. At University of Queensland she is also the Executive Director of the Pacific Malaria Initiative Support Centre and Director of the Health Information Systems Knowledge Hub, and co-coordinator of the Asia Pacific Malaria Elimination Network Secretariat. She has extensive experience in project and programme design in health and development, and for a variety of international development partner and NGO organizations. From 2003-2009 she was the Chair of the WHO Human Reproduction Country Policy And Programme Development Panel, and is now a member of the WHO Research Project Review Panel (amalgamation of the previous and other panels) of the Department of Reproductive Health and Research including the WHO Special Programme Of Research, Development And Research Training In Human Reproduction.

Maxine Whittaker remains active in scientific research especially in fields of operational and health services research and medical anthropology, and been involved in and managed a variety of field based research programmes and grants in including in Solomon Islands, Vanuatu, Papua New Guinea, Bangladesh, Zambia, Zimbabwe and Kenya. She has a special interest in the issue of scaling-up pilot programmes into policy and practice, and as a founding member of Expandnet has contributed to a body of work recently published by WHO on this topic. Since 1986 Professor Whittaker has conducted research into the improvement of health services and systems in development settings including for major infectious diseases, maternal and child health and sexual and reproductive health. This has included piloting of innovation in a range of health settings in rural settings in Southern and Eastern Africa, Bangladesh, Papua New Guinea, Solomon Islands, Vanuatu, North-west china, Philippines and Vietnam. This work has included ways of successfully scaling up pilots into country programmes, and has been embodied in a series of work published by WHO with Expandnet, developed through Rockefeller and Hewlett Foundation funding. In Papua New Guinea the work was linked between the PNG Institute of Medical Research and the National Department of Health, and focused on infectious diseases including malaria. Link to ACITH.


Dr Charlene Willis

Charlene Willis obtained her BSc and MSc from the University of Otago, NZ, before completing her training at the University of Queensland, AUS in 2008. Currently at the University of Queensland; her primary research focus involves characterisation of secreted gut molecules in Schistosoma mansoni with an aim of identifying proteins that are essential to this and other blood feeding helminthes. Key interests include protein expression and purification, immunohistochemical localization, and RNA interference. 

Dr David Wilson

Dr David Wilson is the Senior Technical Officer responsible for the Advanced Proteomics Facility and the Advanced NMR Facility at James Cook University, Cairns Campus. He has more than 10 years academic and industry research experience, and graduated with an MBA in 2009. Dr Wilson's research interests focus on the venom components of toxic creatures, particularly spiders. He is a senior investigator on a National Breast Cancer Foundation grant to investigate the potential of Australian spider venoms as therapeutic leads in the treatment of breast cancer.


Dr Jennifer Wilson

Dr Jennifer Wilson is research leader at the Institute for Glycomics, Griffith University.  Her research interests include the application of biomolecular NMR to understanding the biosynthetic pathways of carbohydrates in disease-causing bateria, through elucidating the structure of bacterial glycans and the function of glycosyltransferases and the application of this knowledge for the design of carbohydrate-based vaccine candidates.  She also has a long-standing interest in bacterial sialidases and their role in disease, exploiting bacterial enzymes in the production of complex synthetic carbohydrates.  She has a developing interest in understanding chemotaxis, adhesion and invasion of host cells by pathogenic bacteria through interaction wtih carbohydrate receptors. Link to profile.


Dr Michelle Wykes

Dr Michelle Wykes is a Smart Futures Fellow at the Queensland Institute of Medical Research. She has expertise in Dendritic cell biology of infectious diseases and is interested in understanding the pathogenesis of Malaria. Her group studies the molecular basis of immunity against malaria using model systems and their role in pathogenesis of disease. Link to research group.




Professor Ross Young

Executive Dean of the Faculty of Health, Professor Ross Young, is a clinical psychologist with a research background in integrating genetic and environmental risks for mental illness. He was Executive Director of the Institute of Health and Biomedical Innovation (IHBI) at QUT from 2006 until joining the Faculty of Health in early 2013.

His research includes work in substance misuse, schizophrenia, anxiety disorders and more broadly in behavioural medicine. This includes work in pharmacogenomics and the development of personalised medicine via the use of gene chips.

Professor Young is widely published and has over 150 published papers in genetic, medical, psychiatric and psychological journals including Nature Medicine.  He currently serves on Queensland State and Australian bodies and boards related to health issues. Link to profile.


web design by precedence